Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1997
  • Dowloads 148

Case Reports

Open Access

Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient

  • D. Shintani1
  • H. Yoshida1,*,
  • Y. Imai1
  • K. Fujiwara1

1 Department of Gynecologic Oncology, Saitama Medical University, International Medical Center, Hidaka-city, Saitama, Japan

DOI: 10.12892/ejgo2851.2016 Vol.37,Issue 2,April 2016 pp.286-287

Published: 10 April 2016

*Corresponding Author(s): H. Yoshida E-mail: hiro_y@saitama-med.ac.jp

PDF (654.18 kB) View Full-text

Abstract

A 46-year-old female was treated with a regimen of paclitaxel and carboplatin (TC therapy) as adjuvant chemotherapy for Stage IC ovarian adenocarcinoma. There was no severe toxicity except for grade 3 neutropenia during the first four cycles of TC therapy. However, she developed acute pancreatitis at 14 days after fifth cycle. TC therapy is commonly associated with adverse effects such as myelosuppression, hypersensitivity, alopecia, and peripheral neuropathy, but acute pancreatitis has rarely been reported. Ovarian cancer patients often present with nausea and abdominal pain, which are the same symptoms of pancreatitis. It is very important to keep in mind that acute pancreatitis may be concealed in these common symptoms of ovarian cancer during and after TC therapy. Because acute pancreatitis is fatal complication and quitting the drug usually leads to complete cure. The authors report an uncommon case in which TC therapy may have caused acute pancreatitis.

Keywords

Paclitaxel; Carboplatin; Acute pancreatitis; Ovarian cancer.

Cite and Share

D. Shintani,H. Yoshida,Y. Imai,K. Fujiwara. Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient. European Journal of Gynaecological Oncology. 2016. 37(2);286-287.

URL:

https://www.ejgo.net/articles/10.12892/ejgo2851.2016

References

[1] Siegel R., Naishadham D., Jemal A.: “Cancer statistics, 2013”. CA Cancer J. Clin., 2013, 63, 11.

[2] Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., et al.: “Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study”. J. Clin. Oncol., 2003, 21, 3194.

[3] Badalov N., Baradarian R., Iswara K., Li J., Steinberg W., Tenner S.: “Drug-induced acute pancreatitis: an evidence-based review”. Clin. Gastroenterol. Hepatol., 2007, 5, 648.

[4] Nitsche C.J., Jamieson N., Lerch M.M., Mayerle J.V.: “Drug-induced pancreatitis”. Best Pract. Res. Clin. Gastroenterol., 2010, 24, 143.

[5] Kaplan M.H., Dreiling D.A.:“Steroids revisited. II. Was cortisone responsible for the pancreatitis?” Am. J. Gastroenterol., 1997, 67, 141.

[6] Alberti-Flor J.J.: “Pancreatitis associated with ondansetron”. J. Natl. Cancer Inst., 1995, 87, 689.

[7] Kumar D.M., Sundar S., Vasanthan S.: “A case of paclitaxel induced pancreatitis”. Clin. Oncol., 2003, 15, 35.

[8] Singh V., Devata S., Cheng Y.C.: “Carboplatin and docetaxelinduced acute pancreatitis: brief report”. Int. J. Clin. Oncol., 2010, 15, 642.

[9] Garg R., Agarwala S., Bhatnagar V.: “Acute pancreatitis induced by ifosfamide therapy”. J. Pediatr. Surg., 2010, 45, 2071.

Submission Turnaround Time

Top